These data suggest that activation of MR by aldosterone inhibits the growth of certain subtypes of GBM cells and suppresses the self-renewal of glioma stem cells, which is in line with the observation that reduced expression of MR correlates with poor survival in those subtypes. Here, NR3C2 is linked to glioma.